We have a growing team of highly skilled scientists all of whom work out of our laboratory in Nottingham. Together, they combine their experience to design and develop bespoke assays to meet clients’ needs
Dr Shailendra R Singh
Founder and Chief Executive Officer
Shailendra Singh is an experienced life science research scientist with over 18 years’ academic and commercial experience in diagnostic, pharmaceutical and biotech/biomedical sectors.
Originally qualifying as a medical doctor specializing in immunology, he then went on to train as a Pathologist and Immunologist. This led to his appointment as a Laboratory Operations Manager for Thyrocare Technologies Ltd., one of the leading Diagnostic Laboratories in India. He then went on to complete his Master of Research and PhD in Molecular Medicine from University of Nottingham, UK.
With years of combined experience working as a Postdoctoral Research Scientist in UK-based universities and as a Senior Discovery Scientist with hVIVO Services Ltd, he then went on to establish his own company, Cellomatics BioSciences Ltd, a Nottingham (UK) based preclinical CRO laboratory.
Shailendra has a strong track record in the management of technical/research organisations to cGMP quality standards and in the identification/discovery and characterisation of targets for in vitro validation work.
He is the author of several scientific papers in peer-reviewed journals.
Mr Stuart Gibson
Consultant Finance Director
Stuart has over 20 years experience as a FD/CFO working with growth companies in the life sciences and technology sectors.
He joined Arakis Ltd in 2001 shortly after the company was formed and played a key role in the companies success, culminating in the sale of Arakis to the Japanese quoted pharma company Sosei for over £100M in 2006. Stuart was appointed to the Board of Sosei shortly after and raised further funding on the Tokyo stock market before leaving in 2008. From 2008 to 2015 he worked for ARKeX, a new technology company operating worldwide in the Oil & Gas services sector. During his tenure he lead contract negotiations with customers and business partners globally including North Africa, Middle East and China.
In 2015 Stuart set up his own consultancy buisness, Brosnaich Ventures Ltd, and works with a small portfolio of life science companies, including Cellomatics, to provide financial and corporate management support.
Dr Anushuya Tamang
Study and Operations Director
Anushuya holds a PhD in Developmental Biology and Embryology, and M.Res in Cancer Biology from Nottingham Trent University, UK. Her PhD research focused on “The differential expression of Cancer Testis Antigens and 5-HT Receptors in Normotensive and Pre-eclamptic Placentae, and their role in trophoblast invasion”.
During her PhD, she also worked as a part-time Lecturer for Pharmacology and Bioscience Department at Nottingham Trent University.
She completed her MSc and BSc in Biotechnology from Bangalore University, India. Following her university studies, she worked as Senior Scientific Analyst at Molecular Connections for over a year. As Senior Scientific Analyst, her responsibilities included data curation/ mining of scientific research articles/patents for developing data banks for clients and web search engines. She was also responsible for regularly training junior analysts and for the quality assurance of the team.
She has more than 12 years of experience in molecular and cellular biology, as well as histology.
Professor David G Lambert
David is a Professor of Anaesthetic Pharmacology and Deputy Head of Cardiovascular Sciences Department at the University of Leicester, UK.
He trained as a biologist then carried out his PhD in Diabetes Research (1987). This was followed by post-doctoral ‘conversion’ to Pharmacology in Leicester, after which he then moved to Anaesthesia in Leicester in 1991 where he has since been Lecturer, Senior Lecturer, Reader and Full Professor.
His research interests are predominantly related to peptides and their receptors with emphasis on opioids/pain. He has additional disease interests in sepsis and cancer (angiogenesis). He has an extensive publications list and an h-index 54. Publications include a book (Calcium Signaling Protocols) in 3rd edition and one patent. He is Fellow of the Royal College of Anaesthetists and also their Faculty of Pain Medicine, Fellow of the British Pharmacological Society and Senior Fellow of the Higher Education Academy. He chairs the board of The British Journal of Anaesthesia.
Senior Director, Customer Engagement
Anand has built a career for nearly 25 years in the Technology Consulting and Outsourcing sector. He began as a Product Architect in a VC funded start-up in Germany. He has since held a number of senior and executive leadership roles with Tier 1 Technology Systems Integrators such as Capgemini, covering Strategy, M&A, Sales and Marketing, Project Management and Operations. During these years, he has opened businesses with the likes of Google, Microsoft, Amazon, McDonald’s and Coca Cola and scaled them to multi-million dollar accounts. He has managed businesses that have served inter-governmental and non-profit agencies such as The UN and The World Bank.
Anand has worked across the US, UK, Europe, India, and the Far East. He has managed people from across a spectrum of ethnicities, nationalities, demographic cohorts, gender identities and cognitive strengths. He now spends time helping a portfolio of entrepreneurs to scale their businesses.
He lives in Surrey, England. He has a Bachelor’s Degree in Zoology from the University of Mumbai and he is a qualified Executive Coach from the Henley School of Business.
Request a consultation with Cellomatics Biosciences today
Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.
To request a consultation where we can discuss your exact requirements, please contact a member of the team.